Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 16,069Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Xeljanz

02 1Xeljianz

PharmaCompass

01

Brand Name : Xeljanz

Tofacitinib Citrate

arrow
2024 ACI Convention
Not Confirmed

02

Brand Name : Xeljanz

Tofacitinib Citrate

arrow
2024 ACI Convention
Not Confirmed

03

Brand Name : Xeljanz

Tofacitinib Citrate

arrow
2024 ACI Convention
Not Confirmed

04

Brand Name : Xeljanz

Tofacitinib Citrate

arrow
2024 ACI Convention
Not Confirmed

05

Brand Name : Xeljanz

Tofacitinib Citrate

arrow
2024 ACI Convention
Not Confirmed

06

Brand Name : Xeljanz

Tofacitinib citrate

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Xeljanz

arrow
2024 ACI Convention
Not Confirmed

Tofacitinib citrate

Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

Currency : USD

2015 Revenue in Millions : 308

2014 Revenue in Millions : 523

Growth (%) : 70%

blank

07

Brand Name : Xeljianz

Tofacitinib citrate

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Xeljianz

arrow
2024 ACI Convention
Not Confirmed

Tofacitinib citrate

Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

Currency : USD

2014 Revenue in Millions : 170.20%

2013 Revenue in Millions :

Growth (%) :

blank

08

Brand Name : Xeljanz

Tofacitinib Citrate

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Xeljanz

arrow
2024 ACI Convention
Not Confirmed

Tofacitinib Citrate

Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

Currency : USD

2016 Revenue in Millions : 927

2015 Revenue in Millions : 524

Growth (%) : 77

blank

09

Brand Name : Xeljanz

Tofacitinib Citrate

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Xeljanz

arrow
2024 ACI Convention
Not Confirmed

Tofacitinib Citrate

Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

Currency : USD

2017 Revenue in Millions : 1,345

2016 Revenue in Millions : 927

Growth (%) : 45

blank

10

Brand Name : Xeljanz

Tofacitinib Citrate

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Xeljanz

arrow
2024 ACI Convention
Not Confirmed

Tofacitinib Citrate

Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

Currency : USD

2018 Revenue in Millions : 1,773

2017 Revenue in Millions : 1,345

Growth (%) : 32%

blank